Proton Therapy

Proton Therapy (PT) is today the most advanced method to fight against several types of cancer. Moreover, proton accelerators are used for the production of radioactive isotopes for medical purposes. Since 2003 Cryoelectra supplies Solid State Amplifiers, LLRF Control Systems, and Diagnostic Systems for proton accelerators. The reliabilty of Cryoelectra's RF systems is well approved as single supplier for the Proton Therapy Cyclotrons of Varian Medical PT.

The outstanding performances are:

- max. reliability due to high redundancy concept,

- sophisticated control system allowing on-site teams

the easy operation of the systems,

- unbureaucratic customer support, remote

as well as on-site the PT clinics.

CRE-312A/B/C SSA

72 MHz 150 kW CW

20 amplifiers are delievered so far (3 MW), 4 are under production. For each PT system, Varian uses one SSA and one DLLRF system.

Varian Medical Systems Proton Therapy

Juni 2009 - 2019

world wide PT systems

CRE-207A Digital LLRF

72 MHz

24 Systems were delivered so far, 2 are under production.

Varian Medical Systems Proton Therapy

Oct 2008 - 2019

world wide PT systems

CRE-368A SSA

91.5 MHz 80 kW CW

Chinese companies start to develop their own proton therapy systems. Cryoelectra has delivered a SSA to one of the first systems built in China.

Hefei CAS Ion Medical and Technical Devices Co. Ltd.

Jan 2017 - 2018

Hefei, China

CRE-223A DLLRF 91.5 MHz

Chinese companies start to develop their own proton therapy systems. Cryoelectra has delivered a DLLRF to one of the first systems built in China.

Hefei CAS Ion Medical and Technical Devices Co. Ltd.

Jan 2017 - 2018

Hefei, China

CRE-307A SSA

176 MHz, 2.5 kW CW

6 Solid State Amplifiers (each 2.5 kW CW) delivered for a p-LINAC with super-conducting Halve-Wave-resonators for radioactive isotope production.

SARAF-project phase I, SOREQ, Israel

2006 - 2008

CRE-201A LLRF

176 MHz

6 semi digital LLRF Control systems delivered for the super-conducting Halve-Wave-resonators of a p-LINAC for radioactive isotope production and one for the RFQ.